local
An experimental Alzheimer's drug is showing some promise
By AP via Scripps News Group at KXXV (ABC 25) News
· July 14, 2026
· 5 min read
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments by lowering levels of a brain protein called tau, researchers reported Tuesday.Tau is one part of a toxic duo fueling Alzheimer's but prior attempts to develop drugs that can target...
Key takeaway Two Alzheimer's drugs, lecanemab and donanemab, try to clear buildup of the better-known amyloid protein and can modestly slow cognitive decline.
Why this matters in The Waco
The potential breakthrough in Alzheimer's treatment has significant implications for Waco residents, where the disease affects a substantial number of families. As the population ages, the need for effective treatments becomes increasingly pressing. The experimental drug diranersen, which targets the tau protein, offers a new avenue for research and potential relief for those affected. Locally, this development may lead to increased investment in Alzheimer's research and care, potentially benefiting area hospitals and medical facilities. Additionally, the study's findings may also raise awareness about the importance of addressing dementia in McLennan County, prompting community discussions about support services and resources for caregivers and patients. As Biogen plans a larger study to prove the drug's benefit, Waco residents will be watching closely, hoping for a glimmer of hope in the fight against this devastating disease.
About this story
Original reporting by KXXV (ABC 25) News . The Waco surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KXXV (ABC 25) News . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 14, 2026 ·
Source: KXXV (ABC 25) News ·
Reading time: 5 min
Get more The Waco stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments by lowering levels of a brain protein called tau, researchers reported Tuesday.Tau is one part of a toxic duo fueling Alzheimer's but prior attempts to develop drugs that can target...
When was this published? This article was first published on July 14, 2026 by KXXV (ABC 25) News and curated for The Waco readers.
Who reported this story? This story was reported by AP via Scripps News Group at KXXV (ABC 25) News. To learn more about how The Waco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Waco, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter